Medtronic PLC

• Analysts raised price targets citing stabilizing bioprocessing and life sciences sector recovery. • Danaher partnered with NVIDIA to integrate AI into laboratory equipment platforms. • Danaher reported annual revenue of $24.57B and net profit of $3.61B.

• Thermo Fisher showed high volatility ahead of its quarterly earnings release. • Annual revenue reached $44.56B with net profit totaling $6.70B. • Analysts maintain Buy ratings with an average price target of $683.61.

• UnitedHealth raised its full-year adjusted earnings guidance for the third consecutive time. • The medical care ratio improved through tighter cost management and disciplined pricing. • Latest annual revenue reached $447.93B, ranking first in the industry.

• Medtronic completed an oversubscribed exchange offer to divest its diabetes business. • New permanent CPT codes support long-term reimbursement and physician adoption. • Annual revenue reached $36.36B with an average analyst price target of $104.70.

• Humana's stock rose due to favorable Medicare Advantage Star Ratings updates. • Most enrollees are now covered by plans receiving four stars or higher. • Higher ratings unlock federal bonus payments, supporting margin expansion and profitability.

• Thermo Fisher stock fell due to profit-taking and broader healthcare sector weakness. • Investors adopted cautious postures ahead of upcoming third-quarter financial results. • Macroeconomic factors, elevated bond yields, and foreign exchange headwinds weighed on prices.